Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

The Sperm Banking Industry

Cryobanks, Donor Sperm, and Fertility Preservation

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Donor tissue regulated under 21 CFR Part 1271 (HCT/P); banks FDA-registered

Reference only. Not medical advice.

What can go wrong

Not all frozen sperm survives thaw, and severely abnormal samples may not be suitable for all techniques. Donor conception raises long-term considerations around limits on offspring per donor, the erosion of anonymity through consumer DNA testing, and disclosure to donor-conceived people. Storage depends on continued fees and facility integrity; tank failures, though rare, have caused documented losses.

This is something to take to a clinician. The Atlas can tell you what is known about the sperm banking industry in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The sperm-banking industry spans autologous preservation (men freezing their own sperm before cancer treatment, vasectomy, or for personal reasons) and the donor-sperm market (catalogued, screened donors sold to recipients). In the US, donor tissue is regulated under FDA's HCT/P rules (21 CFR Part 1271), and large banks like California Cryobank, Fairfax Cryobank, and Denmark's Cryos International dominate distribution.

A regulated global market in frozen gametes, for preservation and for donor conception.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Fertility preservation before chemotherapy or radiation
  • Preservation before vasectomy or gender-affirming care
  • Donor sperm for single mothers by choice and same-sex couples
  • Backup before assisted reproduction

How it works

Semen is collected, evaluated, and cryopreserved in liquid nitrogen using cryoprotectant media; samples are stored at approximately -196 C, where they remain viable for years. Donor programs add extensive screening: physical exams, medical and genetic history, and infectious-disease testing, with anonymous donors quarantined for six months and retested before release.

What people get wrong

  • Often saidFrozen donor sperm guarantees a healthy baby

    ActuallyDonors are screened for many conditions but no screening is exhaustive; residual genetic and infectious risk exists, and success still depends on the recipient and technique.

  • Often saidSperm degrades quickly in storage

    ActuallyProperly cryopreserved sperm can remain viable for many years; the limiting factors are thaw survival and continued storage maintenance, not time alone.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Revenue accrues to commercial cryobanks (California Cryobank, Fairfax, Cryos, Cryobank America), storage facilities charging recurring fees, and the fertility clinics that pair banking with treatment. The donor-sperm catalogue model resembles a curated marketplace.

What we do not know

  • How should per-donor offspring limits be set and enforced internationally?
  • How does at-home consumer DNA testing reshape donor anonymity and disclosure norms?

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Autologous freezing and storage commonly runs a few hundred dollars upfront plus annual storage fees. Donor sperm vials typically cost several hundred to over a thousand dollars each, with additional fees for shipping, ID-release options, and genetic matching; multiple vials are often needed.

At a glance

Largest sperm bank
Cryos International (Denmark), per company
US regulatory framework
21 CFR Part 1271, effective May 2005
Anonymous donor quarantine
6-month quarantine with repeat infectious-disease testing
Market region leader
North America led the segment (~37% share, 2022 estimates)

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about The Sperm Banking Industry. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • FDA HCT/P regulations (21 CFR Part 1271)2005

    Established screening, testing, and quarantine requirements for donor gametes in the US

  • ASRM donor gamete guidanceongoing

    Recommends donor screening protocols and suggests limits on number of pregnancies per donor